Karsten Lindhardt
Egalet Corporation Wayne, USA
Biography
Karsten Lindhardt has been the initiator of the CCALC Cat 1 focus group, which purpose has been to make meetings for professionals in the abuse deterrence space with a particular interest in the field of in vitro abuse deterrence studies. Dr Lindhardt is the CSO of Egalet Corp. and has 20 years of experience as a scientific manager in the pharmaceutical industry. Dr Lindhardt has earned a Diploma of Business Excellence (DBE) at Columbia University, Copenhagen Business School. Dr Lindhardt received an MSc in Pharmaceutics and a Ph.D. in pharmaceutical development and pharmacology, each from the Royal Danish School of Pharmacy, Copenhagen DK.